Adjuvant transcatheter arterial chemoembolization after curative resection for hepatocellular carcinoma patients with solitary tumor and microvascular invasion: a randomized clinical trial of efficacy and safety

BACKGROUND: The optimal strategy for adjuvant therapy after curative resection for hepatocellular carcinoma (HCC) patients with solitary tumor and microvascular invasion (MVI) is controversial. This trial evaluated the efficacy and safety of adjuvant transcatheter arterial chemoembolization (TACE) a...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Wei, Jian, Pei-En, Li, Shao-Hua, Guo, Zhi-Xing, Zhang, Yong-Fa, Ling, Yi-Hong, Lin, Xiao-Jun, Xu, Li, Shi, Ming, Zheng, Lie, Chen, Min-Shan, Guo, Rong-Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6235393/
https://www.ncbi.nlm.nih.gov/pubmed/30305149
http://dx.doi.org/10.1186/s40880-018-0331-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6235393/
https://www.ncbi.nlm.nih.gov/pubmed/30305149
http://dx.doi.org/10.1186/s40880-018-0331-y

Ejemplares similares